Novo Nordisk Foundation’s innovation initiative, BioInnovation Institute (BII) has awarded EUR 14 million to eight early-stage life science start-ups and research projects.
BII has accepted five early-stage start-up companies into the Creation House life science incubator program with EUR 1.3 million in funding for each start-up company. Among the new life science innovations that have received funding and access to BII’s office and laboratory facilities are three university-based research projects that will be part in BII Faculty. The projects will establish a team that will work alongside the projects and start-ups in the other BII programs. Each Faculty project has been awarded up to EUR 2.4M over three years.